No total survival profit with ICDs in non-ischemic coronary heart failure
Placement of an implantable cardioverter-defibrillator (ICD) in sufferers with non-ischemic systolic coronary heart failure didn't enhance total survival in comparison with traditional medical care -- though a secondary end result, danger of sudden cardiac demise, was halved with ICD placement, in response to new analysis reported right here. Outcomes of the DANISH trial, offered at ESC Congress 2016, with simultaneous publication within the New England Journal of Drugs , recommend a caveat to each European and American Coronary heart Affiliation tips which suggest ICDs for all coronary heart failure, famous research investigator Lars Kober, MD, from Rigshospitalet, Copenhagen College Hospital in Copenhagen, Denmark. "Prophylactic ICD implantation is a category 1 suggestion in sufferers with coronary heart failure and decreased left ventricular systolic perform in each European and American tips," he defined. "Nevertheless, the proof is far weaker for sufferers...